| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2c24cdd0352095fe3b5430ced0126d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d23622a518dfc13cf8ac95b78a9143f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bae25edb6d32a4330f204f6f0bb64695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb04c7b96f62e8d83862f6497831c304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30a4c6440c01a396e591bc7ca080a47e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74fffea6c9faa429b45124dc21599fdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f82cfe65e8121730326e4de873e0fa0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
| filingDate |
2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_103f1ee9151b6cd51f5a1a80f734e081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e258d683caf0e96f053e01b135f453ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d4af2d38fbfb2c9d59bb6d5a0a4574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9e655278323316c8efca062314fb950
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fc78d1ca5453eee330b3509d473951e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4c02c15d53ed92a05bb11118b50dbcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76f16077097ffa62babf6709f8cff121 |
| publicationDate |
2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009054394-A1 |
| titleOfInvention |
Polymorphisms in mgst3 are associated with elevated alat levels after ximelagatran treatment |
| abstract |
This invention relates to a method for administering a pharmaceutically useful anticoagulant drug to certain suitable patients and a method for identifying those patients suitable for receiving the drug. In particular, the invention surrounds the identification of an association between certain SNPs in the MGST3 gene and susceptibility to increased levels of alanine aminotransferase (ALAT) following ximelagatran administration. Thus, this invention relates to methods for predicting susceptibility to elevated ALAT following ximelagatran administration and to methods for administering a pharmaceutically useful anticoagulant drug to certain suitable patients. |
| priorityDate |
2005-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |